Search Results
Results found for "Caldan Therapeutics"
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces
- 📰 GPCR Weekly News - January 2 to 8, 2023
Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics
- 📰 GPCR Weekly News, March 18 to 24, 2024
Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic
- Understanding Enzyme Inhibition In GPCR Discovery Programs
When “inhibition” becomes activation—and how that insight fuels next-gen therapeutic design.
- Interacting binding insights and conformational consequences of the differential activity of...
way for understanding the CBD pharmacology at a molecular level and aid in harnessing its potential therapeutic
- GPCR Collaboration: From Models to Medicine
They offer extraordinary therapeutic promise —but their complexity makes them one of the hardest targets
- Dr. GPCR University registration is now open! Secure your spot now!
the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
When a drug outlives its exposure , toxic interactions can be just as persistent as therapeutic ones.
- Exploring the Breakthroughs in GPCR Research
GPCRs remain one of the most prolific and fertile therapeutic drug targets.
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- 📰 GPCR Weekly News, October 16 to 22, 2023
potential use of Opn5 and its homologs Industry News The Leading GPCR Company in Immuno-Oncology, Domain Therapeutics
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively activate therapeutically analyzing drug-target interactions and disease pathways, AI can identify potential candidates that may have therapeutic
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
understanding how serotonin receptors, one of the largest subfamilies of class A GPCRs and potential therapeutic
- Advantages of Fluorescent Probes in GPCR Assays
GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet
- 📰 GPCR Weekly News, January 23 to 29, 2023
Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
competitive edge: Learn to leverage restricted diffusion and rebinding to create drugs with longer therapeutic
- 📰 GPCR Weekly News, December 4 to 10, 2023
Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics
- 📰 GPCR Weekly News - January 9 to 15, 2023
Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research collaborations GPCR Therapeutics
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic
- 📰 GPCR Weekly News, February 13 to 19, 2023
GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus.
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
accurately reflect native biological processes and preclinical research can more reliably translate into therapeutic Trends in clinical success rates and therapeutic focus. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief
- 📰 GPCR Weekly News, February 5 to 11, 2024
Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024 Domain Therapeutics
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Essential Frameworks for Precision Drug Discovery: An Insight into Advanced Strategies for Targeted Therapeutics
- 📰 GPCR Weekly News, January 8 to 14, 2024
MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic
- 📰 GPCR Weekly News, March 6 to 12, 2023
Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation
- From Failed Experiments to Predictive GPCR Models
increasingly depend on those who can unite modeling with experimentation, turning predictions into real therapeutic
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics













